Florida Senate
-
2026
CS for CS for SB 1760
By
the CommitteeCommittees on Appropriations; and Health Policy; and Senators Brodeur, Gaetz,
Rouson, and Massullo
Senators Brodeur, Gaetz, Rouson, Massullo, Garcia, and Harrell
588-02792-26576-03338-26 20261760c120261760c2
1 A bill to be entitled
12 párrafos sin cambios
2 An act relating to health care coverage; amending s.
3 1.01, F.S.; defining the term “Joint Legislative
4 Committee on Medicaid Oversight”; creating s. 11.405,
5 F.S.; establishing the Joint Legislative Committee on
6 Medicaid Oversight for specified purposes; providing
7 for membership, subcommittees, and meetings of the
8 committee; specifying duties of the committee;
9 authorizing the committee to submit periodic reports
10 to the Legislature; requiring the Auditor General and
11 the Agency for Health Care Administration to enter
12 into and maintain a data sharing agreement for a
13 certain purpose by a specified date; requiring the
14 Auditor General to assist the committee by providing
15 certain staff or consulting services; requiring thatstate
16 state agencies, political subdivisions of the state, and
17 and entities contracted with state agencies to give the
18 committee access to certain records, papers, and
11 párrafos sin cambios
19 documents; authorizing the committee to compel
20 testimony and evidence according to specified
21 provisions; providing for additional powers of the
22 committee; providing that certain joint rules of the
23 Legislature apply to the proceedings of the committee;
24 requiring the agency to notify the committee of
25 certain changes and provide a report containing
26 specified information to the committee; requiring the
27 agency to submit a copy of certain reports to the
28 committee; amending s. 409.962, F.S.; defining terms;
29 amending s. 409.967, F.S.; revising encounter data
30 reporting requirements for prepaid Medicaid plans;
31 requiring that the agency’s analysis of such encounter data
32 todata include identification of specified occurrences;
33 requiring the agency to use such analysis in setting
34 párrafos sin cambios
34 managed care plan capitation rates; requiring that
35 managed care plan contracts require any third-party
36 administrative entity contracted with the plan to
37 adhere to specified requirements; specifying
38 additional types of payments which may not be included
39 in calculating income for purposes of the achieved
40 savings rebate; requiring, rather than authorizing,
41 the agency to calculate the medical loss ratio for all
42 managed care plans under certain circumstances;
43 revising requirements for the calculation of medical
44 loss ratios; requiring the agency to report medical
45 loss ratios quarterly and annually for each managed
46 care plan to the Governor and the Legislature within a
47 specified timeframe; requiring the agency to ensure
48 oversight of affiliated entities and related parties
49 paid by managed care plans; requiring the agency to
50 examine specified records and data related to such
51 entities and parties; requiring the agency to consider
52 certain data and findings when developing managed care
53 plan capitation rates; revising the income sharing
54 ratios used to calculate the achieved savings rebate
55 beginning on a specified date; creating s. 409.9675,
56 F.S.; requiring managed care plans to report to the
57 agency and the Office of Insurance Regulation the
58 existence of and specified details relating to certain
59 affiliations by a specified date and annually
60 thereafter; requiring managed care plans to report any
61 change in such information to the agency and the
62 office in writing within a specified timeframe;
63 requiring the agency to calculate, analyze, and
64 publicly report on the agency’s website an assessment
65 of affiliated entity payment transactions in the
66 Medicaid program and certain administrative costs by a
67 specified date and annually thereafter; providing
68 requirements for the assessment; amending s. 626.8825,
69 F.S.; defining the termsterm “affiliated manufacturer” and;
70 “covered prescription drug”; revising the definition of the term “pharmacy benefits
71 plan or program”; revising requirements for contracts
72 between a pharmacy benefit manager and a participating
73 pharmacy; revising the frequency of and deadlines for
74 certain reports pharmacy benefit managers are required
75 to submit to the office beginning on a specified date;
76 amending s. 626.8827, F.S.; revising and specifying
7177 ofadditional thepractices term “pharmacy benefitsbenefit planmanagers or program”;are
72 revising requirements for contracts between a pharmacy
73 benefit manager and a pharmacy benefits plan or
78 prohibited from engaging in; amending s. 627.42392,
7479 programF.S.; andconforming a participating pharmacycross-reference; revising theproviding
75 frequency of and deadlines for certain reports
76 pharmacy benefit managers are required to submit to
7780 theeffective office beginning on a specified date; amending sdates.
78 626.8827, F.S.; revising and specifying additional
79 practices pharmacy benefit managers are prohibited
80 from engaging in; amending s. 627.42392, F.S.;
81 conforming a cross-reference; providing effective
82 dates.
81
82 Be It Enacted by the Legislature of the State of Florida:
83
84 Be It Enacted by the Legislature of the State of Florida:
85
8684 Section 1. Effective upon this act becoming a law,
8785 subsection (20) is added to section 1.01, Florida Statutes, to
8886 read:
8987 1.01 Definitions.—In construing these statutes and each and
9088 every word, phrase, or part hereof, where the context will
9189 permit:
9290
(20)
The term “Joint Legislative Committee on Medicaid
91
Oversight” means a committee or committees designated by joint
92
rule of the Legislature, by the President of the Senate or the
93
Oversight” means a committee or committees designated by joint
Speaker of the House of Representatives, or by agreement between
94
rule of the Legislature, by the President of the Senate orand the Speaker of the House of
95
Speaker of the House of Representatives, or by agreement between
96
the President of the Senate and the Speaker of the House of
97
Representatives.
9896 Section 2. Effective upon this act becoming a law, section
9997 11.405, Florida Statutes, is created to read:
100
98
11.405
J
oint Legislative Committee on Medicaid
Oversight.
101
99
The
Joint Legislative Committee on Medicaid
Oversight is created
100
to ensure that the state Medicaid program is operating in
101
accordance with the Legislature’s intent and to promote
102
to ensure that the state Medicaid program is operating in
transparency and efficiency in government spending.
103
accordance with the Legislature’s intent and to promote
104
transparency and efficiency in government spending.
105
(1)
3 párrafos sin cambios
MEMBERSHIP;
SUBCOMMITTEES
;
MEETINGS.—
106104
(a)
The committee shall be composed of five
members of the
107105
Senate appointed by the President of the Senate
and five
members
108106
of the House of Representatives appointed by the Speaker of the
109107
House of Representatives
, with each member serving a 2-year
110108
term
. The chair and vice chair shall
each
be appointed for 1
111
109
year terms
,
with the appointments alternating between
the
112110
President of the Senate
and
the Speaker of the House of
113111
Representatives. The chair and vice chair may not be members of
114112
the same house of the Legislature.
If both the chair and vice
113
chair are absent
from
any meeting, the members present
must
114
elect a temporary chair by a majority vote.
115
chair are absent at any meeting, the members present
must
elect
116
a temporary chair by a majority vote.
117
(
b
)
Members shall serve without compensation but may be
116
reimbursed for per diem and travel expenses pursuant to s.
117
112.061.
118
reimbursed for per diem and travel expenses pursuant to s.
119
112.061.
120
(
4 párrafos sin cambios
c
)
The chair may establish subcommittees
as needed
to
121119
fulfill
the committee’s
duties
.
122120
(
5 párrafos sin cambios
d
)
The committee shall convene at
least
twice a year,
and
123121
as often as necessary
3 párrafos sin cambios
to conduct
its
business as required
under
124122
this section
4 párrafos sin cambios
.
M
eetings may be held
through
teleconference or
125123
other electronic means.
126124
(2)
COMMITTEE DUTIES.—
127125
(a)
3 párrafos sin cambios
The
c
ommittee shall evaluate all aspects of the
state
128126
Medicaid program related to program financing, quality
of care
129127
and
health
outcomes, administrative functions, and operational
130
128
functions to ensure
4 párrafos sin cambios
that
the program
is provid
ing
transparency
131
129
in the
4 párrafos sin cambios
provision
of health care plans and providers,
en
sur
ing
132130
Medicaid recipients have
3 párrafos sin cambios
access to quality
health care
service
s
133131
and
5 párrafos sin cambios
providing
stability to
the state
’s budget
through
a health
134132
care delivery system designed to contain cost
s
.
135133
(
b
)
The committee shall identify and recommend policies
136134
that limit Medicaid spend
ing
growth while improving health care
137135
outcomes for
Medicaid
recipients.
In developing its
138136
recommendations, t
he committee shall
do all of the following
:
139137
1.
Evaluate legislation for its long-term impact on
the
140
138
state
Medicaid
program.
141
139
2.
Review data submitted
to the Agency for Health Care
142140
Administration
by the
Medicaid
managed care plans pursuant to
143141
statutory and contract requirements
3 párrafos sin cambios
,
including
,
but not limited
144142
to
,
timeliness of provider credentialing, timely payment of
145143
claims, rate of claim denial
s
, prior authorizations
for
146144
services,
and consumer complaints.
147145
3.
4 párrafos sin cambios
Review
the Medicaid
managed care plan
s’
encounter data,
148146
financial
4 párrafos sin cambios
data,
and audits
and the
data used to calculat
e the
149147
plans’
3 párrafos sin cambios
achieved savings rebate
s
and medical loss ratio
s.
150
148
4.
3 párrafos sin cambios
Review data related to
health
outcomes
of Medicaid
151
149
recipients,
5 párrafos sin cambios
including
,
but not limited to
,
Health
care
152150
Effectiveness Data and Information Set measure
s developed by the
153151
National Committee for Quality Assurance
, for each Medicaid
154152
managed care plan,
each
Medicaid managed care
plan’s performance
155153
improvement projects
,
and outcome data related to all quality
156154
goals included in the Medicaid managed care organization
157155
contracts
to
improve quality for
recipients.
158156
5.
Identify
any areas for
improvement in statu
t
ethe laws and rulerules
159157
relat
4 párrafos sin cambios
ing
to the
state
Medicaid program
.
160
158
6.
Develop a plan of action for the future of the
state
161
159
Medicaid program.
162160
(
4 párrafos sin cambios
c
)
The committee may
submit
periodic reports, including
163161
recommendations, to the Legislature on issues related to
the
164162
state Medicaid program and any affiliated
programs.
165163
(3)
COOPERATION.—
166164
(a)
The Auditor General and the Agency for Health Care
167165
Administration shall enter into and maintain a data
sharing
168166
agreement by July 1, 202
5 párrafos sin cambios
6,
to ensure the
c
ommittee ha
s
full
169167
access to all data needed to fulfill
its
responsibilities.
170
168
(b)
The Auditor General shall assist the
c
ommittee in its
171
169
work by providing credentialed professional staff or consulting
172170
services
, including, but not limited to,
an actuary not
173171
associated with
3 párrafos sin cambios
the state
Medicaid
p
rogram or any Medicaid
172
managed care organization who currently has a contract with the
173
state.
174
managed care organization who currently has a contract with the
175
state.
176
(c)
6 párrafos sin cambios
The
c
ommittee
, in the course
of
its
official duties,
177175
must be given
4 párrafos sin cambios
access to any
relevant record,
paper
,
or document
176
in possession of a state agency, any political subdivision of
177
the state, or any entity engaged in business or under contract
178
in possession of a state agency, any political subdivision of
179
the state, or any entity engaged in business or under contract
180
with a state agency,
and may compel the attendance
and testimony
181
179
of any
3 párrafos sin cambios
s
tate official or employee before the
c
ommittee or secure
182180
any evidence
as provided in s. 11.143. The committee may also
183181
have any other powers conferred on it by
joint rules of the
182
Senate and the House of Representatives, and any joint rules of
183
the Senate and the House of Representatives applicable to joint
184
Senate and the House of Representatives, and any joint rules of
185
the Senate and the House of Representatives applicable to joint
186
legislative committees
apply to the proceedings of the
c
ommittee
187185
under this section
.
188186
(4)
AGENCY REPORTS.—
189187
(a)
Before
implementing any change to the Medicaid managed
190
188
care capitation rates, the
Agency for Health Care Administration
191189
shall notify
the committee of the change
and appear before the
192190
c
ommittee
to
provide a report detailing the managed care
193191
capitation rates and administrative costs built into the
194192
capitation rates. The report
3 párrafos sin cambios
must
include the
agency
’s
193
historical and projected Medicaid program expenditure and
194
utilization trend rates by Medicaid program and service category
195
historical and projected Medicaid program expenditure and
for the rate year, an explanation of
the manner in which
the
196
utilization trend rates by Medicaid program and service category
trend rates were calculated
,
and the policy decisions that were
197
for the rate year, an explanation of how the trend rates were
198
calculatedincluded in
,
and the policy decisions that were included in
199
setting
the capitation rates.
200
198
(b)
3 párrafos sin cambios
If
the
Agency for Health Care Administration
or any
201
199
division within the
a
gency is required by law to report to the
202200
Legislature or to any
legislative
committee or subcommittee on
203201
matters relating to the
4 párrafos sin cambios
state
Medicaid program, the
a
gency
must
204202
also
3 párrafos sin cambios
submit
a copy of the report to the
c
ommittee.
205203 Section 3. Present subsections (2) through (5), (6) through
206204 (10), and (11) through (18) of section 409.962, Florida
207205 Statutes, are redesignated as subsections (3) through (6), (8)
208206 through (12), and (14) through (21), respectively, and new
209207 subsections (2), (7), and (13) are added to that section, to
210208 read:
211209 409.962 Definitions.—As used in this part, except as
212210 otherwise specifically provided, the term:
213211
(2) “Affiliate
,
” including the terms “affiliated with” and
214212
“affiliation
4 párrafos sin cambios
,
” means a person
, as construed in s. 1.01(3),
who
:
215213
(a)
3 párrafos sin cambios
D
irectly or indirectly
,
through one or more
216214
intermediaries
,
controls, is controlled by, or is under common
217215
control with a specified entity or person
, including
parent
and
218216
subsidiary
entities; or
219217
(b)
Is deemed a “related party” according to the standards
218
adopted by the Financial Accounting Standards Board.
219
(7) “Control,” including the terms “controlling,”
220
adopted by the Financial Accounting Standards Board.
“controlled by,” and “under common control with,” means the
221
(7) “Control,” including the terms “controlling,”
possession, direct or indirect, of the power to direct or cause
222
“controlled by,” and “under common control with,” means the
the direction of the management and policies of a person,
223
possession, direct or indirect, of the power to direct or cause
whether through the ownership or voting securities, by contract
224
the direction of the management and policies of a person,
other than a commercial contract for goods or nonmanagement
225
whether through the ownership or voting securities, by contract
services, or otherwise, unless the power is the result of an
226
other than a commercial contract for goods or nonmanagement
official position with or corporate office held by the person.
227
services, or otherwise, unless the power is the result of an
228
official position with or corporate office held by the person.
229
This definition applies
regardless of whether such power is
230
228
affirmative or negative
or
whether such power is actually used
.
231
229
Control
is
presumed to exist, but is not limited to, when any
232230
affiliate
3 párrafos sin cambios
or
person
, as construed in s. 1.01(3)
:
233231
(a)
Directly or indirectly owns, controls, holds the power
232
to vote, or holds proxies representing 10 percent or more of any
233
class of the voting securities of any other person.
234
to vote, or holds proxies representing 10 percent or more of any
235
class of the voting securities of any other person.
236
(b)
Shares common ownership with any person
;
has an
237235
investor or is a holder of an ownership interest
in
any person
;
236
exercises control in any manner over the election of a majority
237
of the directors or of individuals exercising similar functions
238
exercises control in any manner over the election of a majority
239
of the directors or of individuals exercising similar functions
240
of any person
;
has the power to exercise controlling influence
241
239
over the management of any person
;
or serves as a working
242240
majority of the board of directors,
the
managers, or the
243241
officers of a person, who is:
244242
1.
A provider
or a member of a
provider group or group
245243
practice
3 párrafos sin cambios
as
defined in s. 456.053
(3) under
the managed care
246244
plan
;
or
247245
2.
A person responsible for providing any pharmacy
246
services, pharmaceuticals, diagnostics, care coordination, care
247
delivery, health care services, medical equipment,
248
services, pharmaceuticals, diagnostics, care coordination, care
249
delivery, health care services, medical equipment,
250
administrative services, or financial services
under
the managed
251
249
care plan.
252250
(13)
4 párrafos sin cambios
“
Market rate
”
means t
he price that a willing buyer
253251
will
4 párrafos sin cambios
pay and a willing seller
will
accept in an arm
’
s-length
254252
transaction
which
is beneficial to both parties.
255253 Section 4. Subsections (1) and (2), paragraph (h) of
256254 subsection (3), and subsection (4) of section 409.967, Florida
257255 Statutes, are amended, and subsection (5) is added to that
258256 section, to read:
259257 409.967 Managed care plan accountability.—
260258 (1)
CONTRACT PROCUREMENT PROCESS.—
Beginning with the
261259 contract procurement process initiated during the 2023 calendar
262260 year, the agency shall establish a 6-year contract with each
263261 managed care plan selected through the procurement process
264262 described in s. 409.966. A plan contract may not be renewed;
265263 however, the agency may extend the term of a plan contract to
266264 cover any delays during the transition to a new plan. The agency
267265 shall extend until December 31, 2024, the term of existing plan
268266 contracts awarded pursuant to the invitation to negotiate
269267 published in July 2017.
270268 (2)
CONTRACT REQUIREMENTS.—
The agency shall establish such
271269 contract requirements as are necessary for the operation of the
272270 statewide managed care program. In addition to any other
273271 provisions the agency may deem necessary, the contract must
274272 require:
275273 (a)
Physician compensation.
—Managed care plans are expected
276274 to coordinate care, manage chronic disease, and prevent the need
277275 for more costly services. Effective care management should
278276 enable plans to redirect available resources and increase
279277 compensation for physicians. Plans achieve this performance
280278 standard when physician payment rates equal or exceed Medicare
281279 rates for similar services. The agency may impose fines or other
282280 sanctions on a plan that fails to meet this performance standard
283281 after 2 years of continuous operation.
284282 (b)
Emergency services.
—Managed care plans shall pay for
285283 services required by ss. 395.1041 and 401.45 and rendered by a
286284 noncontracted provider. The plans must comply with s. 641.3155.
287285 Reimbursement for services under this paragraph is the lesser
288286 of:
289287 1. The provider’s charges;
290288 2. The usual and customary provider charges for similar
291289 services in the community where the services were provided;
292290 3. The charge mutually agreed to by the entity and the
293291 provider within 60 days after submittal of the claim; or
294292 4. The Medicaid rate, which, for the purposes of this
295293 paragraph, means the amount the provider would collect from the
296294 agency on a fee-for-service basis, less any amounts for the
297295 indirect costs of medical education and the direct costs of
298296 graduate medical education that are otherwise included in the
299297 agency’s fee-for-service payment, as required under 42 U.S.C. s.
300298 1396u-2(b)(2)(D). For the purpose of establishing the amounts
301299 specified in this subparagraph, the agency shall publish on its
302300 website annually, or more frequently as needed, the applicable
303301 fee-for-service fee schedules and their effective dates, less
304302 any amounts for indirect costs of medical education and direct
305303 costs of graduate medical education that are otherwise included
306304 in the agency’s fee-for-service payments.
307305 (c)
Access.
—
308306 1. The agency shall establish specific standards for the
309307 number, type, and regional distribution of providers in managed
310308 care plan networks to ensure access to care for both adults and
311309 children. Each plan must maintain a regionwide network of
312310 providers in sufficient numbers to meet the access standards for
313311 specific medical services for all recipients enrolled in the
314312 plan. The exclusive use of mail-order pharmacies may not be
315313 sufficient to meet network access standards. Consistent with the
316314 standards established by the agency, provider networks may
317315 include providers located outside the region. Each plan shall
318316 establish and maintain an accurate and complete electronic
319317 database of contracted providers, including information about
320318 licensure or registration, locations and hours of operation,
321319 specialty credentials and other certifications, specific
322320 performance indicators, and such other information as the agency
323321 deems necessary. The database must be available online to both
324322 the agency and the public and have the capability to compare the
325323 availability of providers to network adequacy standards and to
326324 accept and display feedback from each provider’s patients. Each
327325 plan shall submit quarterly reports to the agency identifying
328326 the number of enrollees assigned to each primary care provider.
329327 The agency shall conduct, or contract for, systematic and
330328 continuous testing of the provider network databases maintained
331329 by each plan to confirm accuracy, confirm that behavioral health
332330 providers are accepting enrollees, and confirm that enrollees
333331 have access to behavioral health services.
334332 2. Each managed care plan must publish any prescribed drug
335333 formulary or preferred drug list on the plan’s website in a
336334 manner that is accessible to and searchable by enrollees and
337335 providers. The plan must update the list within 24 hours after
338336 making a change. Each plan must ensure that the prior
339337 authorization process for prescribed drugs is readily accessible
340338 to health care providers, including posting appropriate contact
341339 information on its website and providing timely responses to
342340 providers. For Medicaid recipients diagnosed with hemophilia who
343341 have been prescribed anti-hemophilic-factor replacement
344342 products, the agency shall provide for those products and
345343 hemophilia overlay services through the agency’s hemophilia
346344 disease management program.
347345 3. Managed care plans, and their fiscal agents or
348346 intermediaries, must accept prior authorization requests for any
349347 service electronically.
350348 4. Managed care plans serving children in the care and
351349 custody of the Department of Children and Families must maintain
352350 complete medical, dental, and behavioral health encounter
353351 information and participate in making such information available
354352 to the department or the applicable contracted community-based
355353 care lead agency for use in providing comprehensive and
356354 coordinated case management. The agency and the department shall
357355 establish an interagency agreement to provide guidance for the
358356 format, confidentiality, recipient, scope, and method of
359357 information to be made available and the deadlines for
360358 submission of the data. The scope of information available to
361359 the department shall be the data that managed care plans are
362360 required to submit to the agency. The agency shall determine the
363361 plan’s compliance with standards for access to medical, dental,
364362 and behavioral health services; the use of medications; and
365363
follow-up
followup
on all medically necessary services
366364 recommended as a result of early and periodic screening,
367365 diagnosis, and treatment.
368366 (d)
Quality care.
—Managed care plans shall provide, or
369367 contract for the provision of, care coordination to facilitate
370368 the appropriate delivery of behavioral health care services in
371369 the least restrictive setting with treatment and recovery
372370 capabilities that address the needs of the patient. Services
373371 shall be provided in a manner that integrates behavioral health
374372 services and primary care. Plans shall be required to achieve
375373 specific behavioral health outcome standards, established by the
376374 agency in consultation with the department.
377375 (e)
Encounter data.
—The agency shall maintain and operate a
378376 Medicaid Encounter Data System to collect, process, store, and
379377 report on covered services provided to all Medicaid recipients
380378 enrolled in prepaid plans.
381379 1. Each prepaid plan must comply with the agency’s
382380 reporting requirements for the Medicaid Encounter Data System.
383381 Prepaid plans must submit encounter data
, including data on
382
encounters for which payment was denied and encounters for which
383
a health care provider was reimbursed by the plan on a capitated
384
encounters for which payment was denied and encounters for which
385
a health care provider was reimbursed by the plan on a capitated
386
basis,
electronically in a format that complies with the Health
387385 Insurance Portability and Accountability Act provisions for
388386 electronic claims and in accordance with deadlines established
389387 by the agency. Prepaid plans must certify that the data reported
390388 is accurate and complete.
391389 2. The agency is responsible for validating the data
392390 submitted by the plans. The agency shall develop methods and
393391 protocols for ongoing analysis of the encounter data that
394392 adjusts for differences in characteristics of prepaid plan
395393 enrollees to allow comparison of service utilization among plans
396394 and against expected levels of use. The analysis shall be used
397395 to identify possible cases of
overspending on administrative
398396
costs, payments by plans in excess of market rates,
systemic
399397 underutilization or denials of claims and inappropriate service
400398 utilization such as higher-than-expected emergency department
401399 encounters
, and potential
managed care plan
fraud, waste, and
402400
abuse
. The analysis shall provide periodic feedback to the plans
403401 and enable the agency to establish corrective action plans when
404402 necessary. One of the focus areas for the analysis shall be the
405403 use of prescription drugs.
The analysis shall be used in managed
406404
care plan
3 párrafos sin cambios
capitation
rate
-
setting processes provided under this
407405
part.
408406 3. The agency shall make encounter data available to those
409407 plans accepting enrollees who are assigned to them from other
410408 plans leaving a region.
411409 4. The agency shall annually produce a report entitled
412410 “Analysis of Potentially Preventable Health Care Events of
413411 Florida Medicaid Enrollees.” The report must include, but need
414412 not be limited to, an analysis of the potentially preventable
415413 hospital emergency department visits, hospital admissions, and
416414 hospital readmissions that occurred during the previous state
417415 fiscal year which may have been prevented with better access to
418416 primary care, improved medication management, or better
419417 coordination of care, reported by age, eligibility group,
420418 managed care plan, and region, including conditions contributing
421419 to each potentially preventable event or category of potentially
422420 preventable events. The agency may include any other data or
423421 analysis parameters to augment the report which it deems
424422 pertinent to the analysis. The report must demonstrate trends
425423 using applicable historical data. The agency shall submit the
426424 report to the Governor, the President of the Senate, and the
427425 Speaker of the House of Representatives by October 1, 2024, and
428426 each October 1 thereafter. The agency may contract with a third
429427 party vendor to produce the report required under this
430428 subparagraph.
431429 (f)
Continuous improvement.
—The agency shall establish
432430 specific performance standards and expected milestones or
433431 timelines for improving performance over the term of the
434432 contract.
435433 1. Each managed care plan shall establish an internal
436434 health care quality improvement system, including enrollee
437435 satisfaction and disenrollment surveys. The quality improvement
438436 system must include incentives and disincentives for network
439437 providers.
440438 2. Each managed care plan must collect and report the
441439 Healthcare Effectiveness Data and Information Set (HEDIS)
442440 measures, the federal Core Set of Children’s Health Care Quality
443441 measures, and the federal Core Set of Adult Health Care Quality
444442 Measures, as specified by the agency. Each plan must collect and
445443 report the Adult Core Set behavioral health measures beginning
446444 with data reports for the 2025 calendar year. Each plan must
447445 stratify reported measures by age, sex, race, ethnicity, primary
448446 language, and whether the enrollee received a Social Security
449447 Administration determination of disability for purposes of
450448 Supplemental Security Income beginning with data reports for the
451449 2026 calendar year. A plan’s performance on these measures must
452450 be published on the plan’s website in a manner that allows
453451 recipients to reliably compare the performance of plans. The
454452 agency shall use the measures as a tool to monitor plan
455453 performance.
456454 3. Each managed care plan must be accredited by the
457455 National Committee for Quality Assurance, the Joint Commission,
458456 or another nationally recognized accrediting body, or have
459457 initiated the accreditation process, within 1 year after the
460458 contract is executed. For any plan not accredited within 18
461459 months after executing the contract, the agency shall suspend
462460 automatic assignment under ss. 409.977 and 409.984.
463461 (g)
Program integrity.
—Each managed care plan shall
464462 establish program integrity functions and activities to reduce
465463 the incidence of fraud and abuse, including, at a minimum:
466464 1. A provider credentialing system and ongoing provider
467465 monitoring, including maintenance of written provider
468466 credentialing policies and procedures which comply with federal
469467 and agency guidelines;
470468 2. An effective prepayment and postpayment review process
471469 including, but not limited to, data analysis, system editing,
472470 and auditing of network providers;
473471 3. Procedures for reporting instances of fraud and abuse
474472 pursuant to chapter 641;
475473 4. Administrative and management arrangements or
476474 procedures, including a mandatory compliance plan, designed to
477475 prevent fraud and abuse; and
478476 5. Designation of a program integrity compliance officer.
479477 (h)
Grievance resolution.
—Consistent with federal law, each
480478 managed care plan shall establish and the agency shall approve
481479 an internal process for reviewing and responding to grievances
482480 from enrollees. Each plan shall submit quarterly reports on the
483481 number, description, and outcome of grievances filed by
484482 enrollees.
485483 (i)
Penalties.
—
486484 1. Withdrawal and enrollment reduction.—Managed care plans
487485 that reduce enrollment levels or leave a region before the end
488486 of the contract term must reimburse the agency for the cost of
489487 enrollment changes and other transition activities. If more than
490488 one plan leaves a region at the same time, costs must be shared
491489 by the departing plans proportionate to their enrollments. In
492490 addition to the payment of costs, departing provider services
493491 networks must pay a per-enrollee penalty of up to 3 months’
494492 payment and continue to provide services to the enrollee for 90
495493 days or until the enrollee is enrolled in another plan,
496494 whichever occurs first. In addition to payment of costs, all
497495 other departing plans must pay a penalty of 25 percent of that
498496 portion of the minimum surplus maintained pursuant to s.
499497 641.225(1) which is attributable to the provision of coverage to
500498 Medicaid enrollees. Plans shall provide at least 180 days’
501499 notice to the agency before withdrawing from a region. If a
502500 managed care plan leaves a region before the end of the contract
503501 term, the agency shall terminate all contracts with that plan in
504502 other regions pursuant to the termination procedures in
505503 subparagraph 3.
506504 2. Encounter data.—If a plan fails to comply with the
507505 encounter data reporting requirements of this section for 30
508506 days, the agency must assess a fine of $5,000 per day for each
509507 day of noncompliance beginning on the 31st day. On the 31st day,
510508 the agency must notify the plan that the agency will initiate
511509 contract termination procedures on the 90th day unless the plan
512510 comes into compliance before that date.
513511 3. Termination.—If the agency terminates more than one
514512 regional contract with the same managed care plan due to
515513 noncompliance with the requirements of this section, the agency
516514 shall terminate all the regional contracts held by that plan.
517515 When terminating multiple contracts, the agency must develop a
518516 plan to provide for the transition of enrollees to other plans,
519517 and phase in the terminations over a time period sufficient to
520518 ensure a smooth transition.
521519 (j)
Prompt payment.
—Managed care plans shall comply with
522520 ss. 641.315, 641.3155, and 641.513.
523521 (k)
Electronic claims.
—Managed care plans, and their fiscal
524522 agents or intermediaries, shall accept electronic claims in
525523 compliance with federal standards.
526524 (l)
Fair payment.
—Provider service networks must ensure
527525 that no entity licensed under chapter 395 with a controlling
528526 interest in the network charges a Medicaid managed care plan
529527 more than the amount paid to that provider by the provider
530528 service network for the same service.
531529 (m)
Itemized payment.
—Any claims payment to a provider by a
532530 managed care plan, or by a fiscal agent or intermediary of the
533531 plan, must be accompanied by an itemized accounting of the
534532 individual claims included in the payment including, but not
535533 limited to, the enrollee’s name, the date of service, the
536534 procedure code, the amount of reimbursement, and the
537535 identification of the plan on whose behalf the payment is made.
538536 (n)
Provider dispute resolution.
—Disputes between a plan
539537 and a provider may be resolved as described in s. 408.7057.
540538 (o)
Transparency.
—Managed care plans shall comply with ss.
541539 627.6385(3) and 641.54(7).
542540
(p)
Third-party administrators.—
The agency′s contract with
541
a managed care plan must require that any third-party
542
administrative entity contracted by the plan adheres to all
543
a managed care plan must require that any third-party
544
administrative entity contracted by the plan adheres to all
545
pertinent requirements
of the Medicaid program
placed on the
546544
plan
under
the plan′s contract with the agency.
547545 (3) ACHIEVED SAVINGS REBATE.—
548546 (h) The following may not be included as allowable expenses
549547 in calculating income for determining the achieved savings
550548 rebate:
551549 1. Payment of achieved savings rebates.
552550 2. Any financial incentive payments made to the plan
553551 outside of the capitation rate.
554552 3. Any financial disincentive payments levied by the state
555553 or Federal Government.
556554 4. Expenses associated with any lobbying or political
557555 activities.
558556 5. The cash value or equivalent cash value of bonuses of
559557 any type paid or awarded to the plan’s executive staff, other
560558 than base salary.
561559 6. Reserves and reserve accounts.
562560 7. Administrative costs, including, but not limited to,
563561 reinsurance expenses, interest payments, depreciation expenses,
564562 bad debt expenses, and outstanding claims expenses in excess of
565563 actuarially sound maximum amounts set by the agency.
566564
8. Payments to affiliate
s as defined in s. 409.962
in
567565
excess of market rates.
568566
569567 The agency shall consider these and other factors in developing
570568 contracts that establish shared savings arrangements.
571569 (4) MEDICAL LOSS
RATIOS
RATIO
.—
572570
(a)
If required
by federal regulations or
as a condition of
573571 a waiver, the agency
must
4 párrafos sin cambios
may
calculate
a
medical loss
ratios
574572
ratio
3 párrafos sin cambios
for
all
managed care plans
contracted with the agency
575573
under this part
4 párrafos sin cambios
. The
calculation
s must
calculation shall
use
576574 uniform financial data collected from all plans
and shall be
577575
computed for each plan on a statewide basis
.
If a plan
576
participates in the managed medical assistance program, the
577
long-term care managed care program, or the pilot program for
578
participates in the managed medical assistance program, the
individuals with developmental disabilities, the agency must
579
long-termcalculate caremedical managedloss careratios program, orfor the pilotplan’s programparticipation forin
580
individuals with developmental disabilities, the agency must
each program separately and, if the plan participates in more
581
calculatethan medicalone lossof ratiosthese programs, for the plan’s overall participation in
582
each program separately and, if the plan participates in more
583
than one of these programs, for the plan’s overall participation
584
in statewide
Medicaid
managed care.
Medical loss ratios must be
585583
calculated and
The method for calculating the medical loss ratio
586584
shall meet the following criteria:
587585
(a) Except as provided in paragraphs (b) and (c),
588586 expenditures
must
shall
be classified in a manner consistent
589587 with
42 C.F.R. part 438
45 C.F.R. part 158
.
590588 (b)
The agency shall report medical loss ratios quarterly
591589
and annually for each
managed care
plan
contracted with the
592590
agency under this part
to the Governor, the President of the
593591
Senate, and the Speaker of the House of Representatives no later
594592
than 6 months after the end of each
such
period
Funds provided
593
by plans to graduate medical education institutions to
594
underwrite the costs of residency positions shall be classified
595
by plans to graduate medical education institutions to
as medical expenditures, provided the funding is sufficient to
596
underwrite the costs of residency positions shall be classified
sustain the positions for the number of years necessary to
597
as medical expenditures, provided the funding is sufficient to
complete the residency requirements and the residency positions
598
sustain the positions for the number of years necessary to
funded by the plans are active providers of care to Medicaid and
599
complete the residency requirements and the residency positions
uninsured patients.
600
funded by the plans are active providers of care to Medicaid and
(c) Before final determination of the medical loss ratio
601
uninsured patients.
for any period, a plan may contribute to a designated state
602
(c) Before final determination of the medical loss ratio
trust fund for the purpose of supporting Medicaid and indigent
603
for any period, a plan may contribute to a designated state
care and have the contribution counted as a medical expenditure
604
trust fund for the purpose of supporting Medicaid and indigent
for the period. Funds contributed for this purpose shall be
605
care and have the contribution counted as a medical expenditure
606
for the period. Funds contributed for this purpose shall be
607
deposited into the Grants and Donations Trust Fund
.
606
(5) AFFILIATED ENTITIES AND RELATED PARTIES.—
607
(a) The agency shall ensure oversight of affiliated
608
(5) AFFILIATED ENTITIES AND RELATED PARTIES.—
entities and related parties paid by managed care plans under
609
(a) The agency shall ensure oversight of affiliated
this part, including, but not limited to, examining financial
610
entitiesrecords and relatedself-referral partiesdata paidof byany managed care plans underplan
611
this part, including, but not limited to, examining financial
612
records and self-referral data of any managed care plan
613
providing services within the
5 párrafos sin cambios
s
tatewide
m
anaged
c
are program
614612
which uses
affiliated entities and related parties.
615613
(b) The agency shall consider data examined under paragraph
616614
(a) and the findings of the annual
assessment
required under s.
617615
409.9675(4) when developing managed care plan capitation rates
618616
under this part.
619617 Section 5. Effective January 1, 2027, paragraph (f) of
620618 subsection (3) of section 409.967, Florida Statutes, is amended,
621619 and paragraph (g) of that subsection is republished, to read:
622620 409.967 Managed care plan accountability.—
623621 (3) ACHIEVED SAVINGS REBATE.—
624622 (f) Achieved savings rebates validated by the certified
625623 public accountant are due within 30 days after the report is
626624 submitted. Except as provided in paragraph (h), the achieved
627625 savings rebate is established by determining pretax income as a
628626 percentage of revenues and applying the following income sharing
629627 ratios:
630628 1. One hundred percent of income up to and including
3
5
631629 percent of revenue shall be retained by the plan.
632630 2.
Thirty
4 párrafos sin cambios
Fifty
percent of income above
3
5
percent and up
633631 to 10 percent shall be retained by the plan, and the other
70
50
634632 percent shall be refunded to the state and adjusted for the
635633 Federal Medical Assistance Percentages. The state share shall be
636634 transferred to the General Revenue Fund, unallocated, and the
637635 federal share shall be transferred to the Medical Care Trust
638636 Fund, unallocated.
639637 3. One hundred percent of income above 10 percent of
640638 revenue shall be refunded to the state and adjusted for the
641639 Federal Medical Assistance Percentages. The state share shall be
642640 transferred to the General Revenue Fund, unallocated, and the
643641 federal share shall be transferred to the Medical Care Trust
644642 Fund, unallocated.
645643 (g) A plan that exceeds agency-defined quality measures in
646644 the reporting period may retain an additional 1 percent of
647645 revenue. For the purpose of this paragraph, the quality measures
648646 must include plan performance for preventing or managing
649647 complex, chronic conditions that are associated with an elevated
650648 likelihood of requiring high-cost medical treatments.
651649 Section 6. Section 409.9675, Florida Statutes, is created
652650 to read:
653651
409.9675
Affiliated entities and controlling interests;
654652
reports required
.—
655653
(1) Each managed care plan contracted by the agency under
656654
this part shall report
all of
the following by March 31, 2027,
657655
for the prior calendar year,
and annually thereafter, to the
658656
agency and the Office of Insurance Regulation in
a
manner
659657
prescribed by the agency:
660
658
(a)
Any person controlled by or affiliated with the managed
661
659
care plan, including, but not limited to, any provider, provider
662660
group, group practice defined in s. 456.053
(3)
, or person
661
responsible for providing any pharmacy services,
662
pharmaceuticals, diagnostics, care coordination, care delivery,
663
responsible for providing any pharmacy services,
health care services, medical equipment, administrative
664
pharmaceuticals, diagnostics, care coordination, care delivery,
services, or financial services for, to, or on behalf of the
665
health care services, medical equipment, administrative
managed care plan.
666
services, or financial services for, to, or on behalf of the
667
managed care plan.
668
(b)
Any affiliation of any kind or nature with any person
667
wh
o
has, either directly or indirectly through one or more
668
intermediaries, an investment or ownership interest representing
669
which has, either directly or indirectly through one or more
10 percent or more, shares common ownership with, or has an
670
intermediaries,investor or a holder of an investment or ownership interest representing 10
671
10 percent or more, shares common ownership with, or has an
672
investor or a holder of an ownership interest representing 10
673
percent or more
with
any person providing pharmacy services,
672
diagnostics, care coordination, care delivery, health care
673
services, medical equipment, administrative services, or
674
diagnostics, care coordination, care delivery, health care
financial services for, to, or on behalf of the managed care
675
services, medical equipment, administrative services, or
plan.
676
financial services for, to, or on behalf of the managed care
677
plan.
678
(2)
For any affiliation reported by a
managed care plan
679677
under subsection (1)
, the report must include all of the
680678
following
:
679
(a) The percentage of ownership or control of any person or
680
affiliate with whom the managed care plan has had business
681
(a) The percentage of ownership or control of any person or
transactions totaling in the aggregate more than $25,000 during
682
affiliate with whom the managed care plan has had business
683
transactions totaling in the aggregate more than $25,000 during
684
the
prior
12-month period in the annual achieved savings rebate
685683
financial r
eport
ing required under s. 409.967(3)
and
686684
identif
ication of
the specific contract or contracts involved in
687685
such business transactions
.
686
(b) Any significant business transactions between the
687
managed care plan and any affiliated person during the 12-month
688
(b) Any significant business transactions between the
689
managed care plan and any affiliated person during the 12-month
690
period in the annual achieved savings rebate
financial r
eport
ing
691689
required under s. 409.967(3)
.
690
(3) Each managed care plan shall report any change in
691
information required by subsection (1) to the agency and the
692
(3) Each managed care plan shall report any change in
693
information required by subsection (1) to the agency and the
694
Office of Insurance Regulation in writing
within
60 days after
695693
the change occurs.
696694
(4)
By December 31, 2026, and annually thereafter, the
697695
agency shall calculate, analyze
,
and publicly report on the
698696
agency’s website an assessment of affiliated entity payment
699697
transactions in the Medicaid
p
rogram for medical benefit and
700
698
administrative costs as reported for purposes of the achieved
701
699
savings rebate. The baseline assessment, at a minimum,
must
702700
include
7 párrafos sin cambios
a
chieved
s
avings
r
ebate transactions
for the years
2021,
703701
2022, and 2023
;
the amount and associated percentage of
704702
affiliated entity payments within the medical loss ratio
;
and
705703
the payment deviation percentages and associated amounts at the
706704
Healthcare Common Procedure Cod
ing System
level for affiliated
707705
entities as compared to nonaffiliated entities.
The assessment
708706
must
also compare payment amounts for value-based or alternative
709707
payment arrangements
.
710708 Section 7. Present paragraphs (b), through (cx), andof (d), and (e)subsection
711709 through (x) of subsection (1) of section 626.8825, Florida Statutes, are redesignated as
710 paragraphs (c) through (z), respectively, a new paragraph (b) is
711 added to that subsection, and present paragraph (u) of
712 Statutes,subsection are(1) redesignated asand paragraphs (c), (d), and (eh), andof subsection (3) of
713 (g) through (z), respectively, new paragraphs (b) and (f) are
714 added to that subsection, and present paragraph (u) of
715 subsection (1), paragraphs (e) and (g) of subsection (2), and
716 paragraphs (c) and (h) of subsection (3) of that section are
717713 that section are amended, to read:
718714 626.8825 Pharmacy benefit manager transparency and
719715 accountability.—
720716 (1) DEFINITIONS.—As used in this section, the term:
721717
(
b
)
“Affiliated manufacturer” means a prescription drug
722
718
manufacturer permitted under
3 párrafos sin cambios
c
hapter 4
99 or
a private label
723
719
distributor as defined in 21 C.F.R. s. 207.1 which
directly or
720
indirectly through one or more intermediaries:
721
1. Has an investment or ownership interest in a pharmacy
722
benefit manager holding a certificate of authority issued under
723
this part;
724
indirectly through one or more intermediaries:
2. Shares common ownership with a pharmacy benefit manager
725
1. Has an investment or ownership interest in a pharmacy
holding a certificate of authority issued under this part; or
726
benefit manager holding a certificate of authority issued under
3. Has an investor or a holder of an ownership interest
727
this part;
which is a pharmacy benefit manager holding a certificate of
728
2. Shares common ownership with a pharmacy benefit manager
authority issued under this part.
729
holding a certificate of authority issued under this part; or
730
3. Has an investor or a holder of an ownership interest
731
which is a pharmacy benefit manager holding a certificate of
732
authority issued under this part.
733
(f) “Covered prescription drug” means any drug or biologic
734
included in a pharmacy benefit manager’s formulary which is paid
735
for as a pharmacy benefit under the plan at any of the plan’s
736
network pharmacies.
737
(
w
v
)
(u)
“Pharmacy benefits plan or program” means a plan or
738730 program that pays for, reimburses, covers the cost of, or
739731 provides access to discounts on pharmacist services provided by
740732 one or more pharmacies to covered persons who reside in, are
741733 employed by, or receive pharmacist services from this state.
742734 1. The term includes, but is not limited to, health
743735 maintenance organizations, health insurers, self-insured
744736 employer health plans, discount card programs, and government
745737 funded health plans, including the Statewide Medicaid Managed
746738 Care program established pursuant to part IV of chapter 409 and
747739 the state group insurance program pursuant to part I of chapter
748740 110.
749741 2. The term excludes such a plan or program under
s. 430.84
750
742
or
chapter 440.
751743 (23) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A
752744 PARTICIPATING PHARMACY BENEFITS PLAN OR PROGRAM.—In addition to anyother otherrequirements in the
753745 requirements in the Florida Insurance Code, alla contractualparticipation contract executed,
754746 arrangements executed, amended, adjusted, or renewed on or after July 1, 2023, that
755 July 1, 2023, which are applicable to pharmacy benefits covered
747 applies to pharmacist services on or after January 1, 2024,
756748 on or after January 1, 2024, between a pharmacy benefit manager and one or more pharmacies or
757749 and a pharmacy benefits plan or programpharmacists, must include, in substantial form, terms that
758750 substantial form, terms that ensure compliance with all of the following requirements, and
759751 following requirements and that, except to the extent not allowed by law, shall supersede
760752 allowed by law, shall supersede any contractual terms in the participation contract to the
761753 contrary:
762 (e) Include network adequacy requirements that meet or
763 exceed Medicare Part D program standards for convenient access
764 to the network pharmacies set forth in 42 C.F.R. s.
765 423.120(a)(1) and that:
766 1. Do not limit a network to solely include affiliated
767 pharmacies;
768 2. Require a pharmacy benefit manager to offer a provider
769 contract to licensed pharmacies physically located on the
770 physical site of providers that are:
771 a. Within the pharmacy benefits plan’s or program’s
772 geographic service area and that have been specifically
773 designated as essential providers by the Agency for Health Care
774 Administration pursuant to s. 409.975(1)(a);
775 b. Designated as cancer centers of excellence under s.
776 381.925, regardless of the pharmacy benefits plan’s or program’s
777 geographic service area;
778 c. Organ transplant hospitals, regardless of the pharmacy
779 benefits plan’s or program’s geographic service area;
780 d. Hospitals licensed as specialty children’s hospitals as
781 defined in s. 395.002; or
782 e. Regional perinatal intensive care centers as defined in
783 s. 383.16(2), regardless of the pharmacy benefits plan’s or
784 program’s geographic service area.
785
786 Such provider contracts must be solely for the administration
787
and
or
dispensing of covered prescription drugs
, including
788
biological products, which are administered through infusions,
789
intravenously injected, or inhaled during a surgical procedure
790
or are covered parenteral drugs,
as part of
onsite
outpatient
791 care;
792 3. Do not require a covered person to receive a
793 prescription drug by United States mail, common carrier, local
794 courier, third-party company or delivery service, or pharmacy
795 direct delivery unless the prescription drug cannot be acquired
796 at any retail pharmacy in the pharmacy benefit manager’s network
754 (c) A prohibition of financial clawbacks, reconciliation
797755 foroffsets, theor coveredoffsets person’sto adjudicated claims. A pharmacy benefits plan or program. Thisbenefit
798 subparagraph does not prohibit a pharmacy benefit manager from
799 operating mail order or delivery programs on an opt-in basis at
800 the sole discretion of a covered person, provided that the
801 covered person is not penalized through the imposition of any
802 additional retail cost-sharing obligations or a lower allowed
803 quantity limit for choosing not to select the mail order or
804 delivery programs;
805 4. For the in-person administration of covered prescription
806 drugs, prohibit requiring a covered person to receive pharmacist
807 services from an affiliated pharmacy or an affiliated health
808 care provider; and
809 5. Prohibit offering or implementing pharmacy networks that
810 require or provide a promotional item or an incentive, defined
811 as anything other than a reduced cost-sharing amount or enhanced
812 quantity limit allowed under the benefit design for a covered
813 drug, to a covered person to use an affiliated pharmacy or an
814 affiliated health care provider for the in-person administration
815 of covered prescription drugs; or advertising, marketing, or
816 promoting an affiliated pharmacy to covered persons. Subject to
817 the foregoing, a pharmacy benefit manager may include an
818 affiliated pharmacy in communications to covered persons
819 regarding network pharmacies and prices, provided that the
820 pharmacy benefit manager includes information, such as links to
821 all nonaffiliated network pharmacies, in such communications and
822 that the information provided is accurate and of equal
823 prominence. This subparagraph may not be construed to prohibit a
824 pharmacy benefit manager from entering into an agreement with an
825 affiliated pharmacy to provide pharmacist services to covered
826 persons.
827 (g) Prohibit a pharmacy benefit manager from instituting a
828 network that requires a pharmacy to meet accreditation standards
829 inconsistent with or more stringent than applicable federal and
830 state requirements for licensure and operation as a pharmacy in
831 this state. However, a pharmacy benefit manager may specify
832 additional specialty networks that require enhanced standards
833 related to the safety and competency necessary to meet the
834 United States Food and Drug Administration’s limited
835 distribution requirements for dispensing any drug that, on a
836 drug-by-drug basis, requires extraordinary special handling
,
837
provider coordination, or clinical care or monitoring
when such
838 extraordinary requirements cannot be met by a retail pharmacy.
839 For purposes of this paragraph, drugs requiring extraordinary
840 special handling are limited to drugs that are subject to a risk
841 evaluation and mitigation strategy approved by the United States
842 Food and Drug Administration and that:
843 1. Require special certification of a health care provider
844 to prescribe, receive, dispense, or administer; or
845 2. Require special handling due to the molecular complexity
846 or cytotoxic properties of the biologic or biosimilar product or
847 drug.
848
849 For participation in a specialty network, a pharmacy benefit
850756 manager may not requirecharge, a pharmacy to meet requirements forwithhold,
851 participation beyond those necessary to demonstrate the
852 pharmacy’s ability to dispense the drug in accordance with the
853 United States Food and Drug Administration’s approved
854 manufacturer labeling.
855 (3) CONTRACTS BETWEEN A PHARMACY BENEFIT MANAGER AND A
856 PARTICIPATING PHARMACY.—In addition to other requirements in the
857 Florida Insurance Code, a participation contract executed,
858 amended, adjusted, or renewed on or after July 1, 2023, that
859 applies to pharmacist services on or after January 1, 2024,
860 between a pharmacy benefit manager and one or more pharmacies or
861 pharmacists, must include, in substantial form, terms that
862 ensure compliance with all of the following requirements, and
863 that, except to the extent not allowed by law, shall supersede
864 any contractual terms in the participation contract to the
865 contrary:
866 (c) A prohibition of financial clawbacks, reconciliation
867 offsets, or offsets to adjudicated claims. A pharmacy benefit
868 manager may not charge, withhold,
offset,
or recoup
any
direct
869757 or indirect remuneration fees, dispensing fees, brand name or
870758 generic effective rate adjustments through reconciliation, or
871759 any other monetary charge, withholding, or recoupments as
872760 related to discounts, multiple network reconciliation offsets,
873761 adjudication transaction fees, and any other instance when
an
874
762
amount
a fee
may be recouped from a pharmacy
if such action
875
763
would result in a reduction in the amount paid to the pharmacy
876764
or pharmacist
. This prohibition does not apply to:
877765 1. Any incentive payments provided by the pharmacy benefit
878766 manager to a network pharmacy for meeting or exceeding
879767 predefined quality measures, such as Healthcare Effectiveness
880768 Data and Information Set measures; recoupment due to an
881769 erroneous claim, fraud, waste, or abuse; a claim adjudicated in
882770 error; a maximum allowable cost appeal pricing adjustment; or an
883771 adjustment made as part of a pharmacy audit pursuant to s.
884772 624.491.
885773 2. Any recoupment that is returned to the state for
886774 programs in chapter 409 or the state group insurance program in
887775 s. 110.123.
888776 (h) The pharmacy benefit manager shall provide a reasonable
889777 administrative appeal procedure to allow a pharmacy or
890778 pharmacist to challenge the maximum allowable cost pricing
891779 information and the reimbursement made under the maximum
892780 allowable cost as defined in s. 627.64741 for a specific drug as
893781 being below the acquisition cost available to the challenging
894782 pharmacy or pharmacist.
895783 1. The administrative appeal procedure must include a
896784 telephone number and e-mail address, or a website, for the
897785 purpose of submitting the administrative appeal. The appeal may
898786 be submitted by the pharmacy or an agent of the pharmacy
899787 directly to the pharmacy benefit manager or through a pharmacy
900788 service administration organization.
The administrative appeal
901
789
process must allow a pharmacy or pharmacist the option to submit
902790
an electronic spreadsheet or similar electronic document
903
791
containing a consolidated administrative appeal representing
904
792
multiple adjudicated claims that share the same drug
and
day
905
793
supply and ha
ve
a date of service occurring within the same
906
794
calendar month.
The pharmacy or pharmacist must be given at
907795 least 30 business days after a maximum allowable cost update or
908796 after an adjudication for an electronic claim or reimbursement
909797 for a nonelectronic claim to file the administrative appeal.
910798 2. The pharmacy benefit manager must respond to the
911799 administrative appeal within 30 business days after receipt of
912800 the appeal.
913801 3. If the appeal is upheld, the pharmacy benefit manager
914802 must:
915803 a. Update the maximum allowable cost pricing information to
916804 at least the acquisition cost available to the pharmacy;
917805 b. Permit the pharmacy or pharmacist to reverse and rebill
918806 the claim in question;
919807 c. Provide to the pharmacy or pharmacist the national drug
920808 code on which the increase or change is based; and
921809 d. Make the increase or change effective for each similarly
922810 situated pharmacy or pharmacist who is subject to the applicable
923811 maximum allowable cost pricing information.
924812 4. If the appeal is denied, the pharmacy benefit manager
925813 must provide to the pharmacy or pharmacist the national drug
926814 code and the name of the national or regional pharmaceutical
927815 wholesalers operating in this state which have the drug
928816 currently in stock at a price below the maximum allowable cost
929817 pricing information.
930818 5.
Beginning August 15, 2026
Every 90 days
, a pharmacy
931819 benefit manager shall report to the office the total number of
932820 appeals received and denied in the preceding
quarter
90-day
933
821
period
, with an explanation or reason for each denial, for each
934822 specific drug for which an appeal was submitted pursuant to this
935823 paragraph.
The deadlines for each filing are March 1 for the
936
824
preceding year
′
s
fourth
quarter; May 15 for each year
the
year
′
s
first
937
825
quarter; August 15 for each year
the
year
′
s
second
quarter; and November
938
826
15 for each year
the
year
′
s
third
quarter.
939827 Section 8. Subsection (7) of section 626.8827, Florida
940828 Statutes, is amended, and subsections (8), (9), and (10) are
941829 added to that section, to read:
942830 626.8827 Pharmacy benefit manager prohibited practices.—In
943831 addition to other prohibitions in this part, a pharmacy benefit
944832 manager may not do any of the following:
945833 (7) Fail to comply with the requirements in s. 624.491 or
946834 s. 626.8825
, or breach contractual terms required under s.
947
835
626.8825
.
948
836
(8) Prohibit or restrict a pharmacy from declining to
949
837
dispense a drug if the reimbursement rate for the drug is less
950
838
than the actual acquisition cost to the pharmacy.
951
839
(
9
) Reimburse a pharmacy less than it reimburses an
952
840
affiliate pharmacy.
953
841
(
10
) Maintain an ownership interest, investment interest,
954
842
or common ownership with an affiliated manufacturer, or share
955
843
any investor or holder of an ownership interest with an
956
844
affiliated manufacturer.
957845 Section 9. Subsection (1) of section 627.42392, Florida
958846 Statutes, is amended to read:
959847 627.42392 Prior authorization.—
960848 (1) As used in this section, the term “health insurer”
961849 means an authorized insurer offering health insurance as defined
962850 in s. 624.603, a managed care plan as defined in
s. 409.962
s.
963
851
409.962(10)
, or a health maintenance organization as defined in
964852 s. 641.19(12).
965853 Section 10. Except as otherwise provided in this act and
966854 except for this section, which shall take effect upon this act
967855 becoming a law, this act shall take effect July 1, 2026.